Mucositis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with cancer receiving chemotherapy 5-fluorouracil (5-FU) bolus as part of chemotherapy protocol at the beginning of treatment (any cycle); Patients over the age of 18;Both sexes;Patients with scores on the Glasgow scale equal to 15.
Exclusion criteria
Exclusion criteria: Be in radiotherapy in the head region or concomitant esophagus to chemotherapy;Possess smoking habits and alcohol during the research;Have a history of tooth sensitivity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the decrease in the degree of mucositis within 7 days after the application of the 5-fluorouracil chemotherapy measured by the Mucositis Scale of the World Health Organization (WHO) from the observation of a variation of at least 5% in the pre-measurement and post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome is the decrease in the degree of mucositis within 14 days after the application of the 5-fluorouracil chemotherapy measured by the Mucositis Scale of the World Health Organization (WHO) from the observation of a variation of at least 5% in the pre-measurement and post intervention. | — |
Countries
Brazil
Contacts
Universidade Federal do Ceará